4//SEC Filing
Levine James E. 4
Accession 0001628280-22-025099
CIK 0001213037other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 8:37 AM ET
Size
5.0 KB
Accession
0001628280-22-025099
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-09-16$1.56/sh+30,000$46,710→ 60,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.555 to $1.56. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 8:37 AM ET
- Size
- 5.0 KB